Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Moderate quality score of 67/100, reflecting stable operating margins and manageable leverage.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Verdict: Solid fundamental quality, though solvency presents a headwind.
Wall Street is cautious, forecasting potential downside. However, capital return yields remain modest, anchored by a strong, well-covered dividend yield.
IRS demonstrates strong business quality with robust profitability and healthy margins. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company is driving exceptional top-line expansion (24.0% 3Y CAGR) paired with highly explosive earnings growth (76.1% EPS 3Y CAGR). This growth is supported by elite operational efficiency, sustaining an impressive 76.2% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $144.7B | +7.1% | +24.0% | +60.6% | +64.4% | |
| EBITDA | $64.3B | — | -42.1% | — | — | |
| Net Income | -$30.2B | +369.8% | -26.6% | — | +50.0% | |
| EPS (Diluted) | $-1529.00 | +4817.2% | +76.1% | +86.4% | — | |
| Free Cash Flow | $31.1B | -99.8% | -86.8% | -43.3% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 62.0% | 64.4% | 60.9% | 53.0% |
| Operating Margin | 76.2% | -26.6% | -8.8% | -5.9% |
| Net Margin | 49.4% | 27.0% | -8.4% | -37.0% |
| FCF Margin | 5.8% | 23.4% | 23.4% | 33.1% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | — | $-0.28 | — | ||
| Q1'26 | — | $0.58 | — | ||
| Q4'25 | — | $1.42 | — | ||
| Q3'25 | — | $1.74 | — | ||
| Q2'25 | — | $0.89 | — | ||
| Q1'25 | — | $0.92 | — | ||
| Q4'24 | — | $-1.50 | — | ||
| Q3'24 | — | $1.26 | — |
Total return is +31.3% (1Y), outperforming the benchmark by +6.3%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +0.0% | -9.3% | — |
| 1Y | +31.3% | +6.3% | +10.3% |
| 3YCAGR | +36.3% | +16.3% | +49.2% |
| 5YCAGR | +38.0% | +25.9% | +111.8% |
| 10YCAGR | +3.3% | -10.3% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about IRSA Inversiones y Representaciones Sociedad Anónima (IRS) valuation, health, and returns.
IRSA Inversiones y Representaciones Sociedad Anónima is estimated to be fair under our discounted cash flow framework. relative multiples indicate the stock is Cheap versus peers compared to industry peers. trading near fair value (DCF: $18.89)
IRSA Inversiones y Representaciones Sociedad Anónima has multiple valuation anchors: DCF Intrinsic Value: $18.89 | Peer Relative Fair Value: $482684.70 | Wall Street Analyst Target: $13.00 (implying -21.8% upside). A convergence of these signals offers higher conviction.
IRSA Inversiones y Representaciones Sociedad Anónima displays good financial health with a composite quality score of 67/100, supported by a Altman Z-Score of -0.2 (distress zone), Piotroski F-Score of 3/9, Return on Invested Capital (ROIC) of 1.5%.
IRSA Inversiones y Representaciones Sociedad Anónima does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
IRSA Inversiones y Representaciones Sociedad Anónima's current growth trajectory is Decelerating. The company achieved +7.1% 1Y revenue growth and +4817.2% 1Y EPS growth, compared to its 3Y revenue CAGR of +24.0%.
Wall Street consensus is Buy based on 2 analysts. The consensus price target represents a -21.8% change from current levels.
Investment risks for IRSA Inversiones y Representaciones Sociedad Anónima include: -30.6% 1-year max drawdown, high beta (1.55x market volatility), elevated distress risk. Volatility risk is characterized by a beta of 1.55x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.